Tag: Sanofi

The US Supreme Court declined to consider Sanofi SA's antitrust lawsuit against Viatris Inc, alleging that the latter had illegally monopolized the market with...

Sanofi and Translate Bio are refiling paperwork on their US$3.2 billion merger to give the agency more time to review. In a Securities and Exchange...

Sanofi has agreed to buy US biotech company Translate Bio in a US$3.2 billion deal, as it bets on next-generation mRNA vaccine technology beyond...

Three major drugmakers persuaded a federal judge to drop antitrust claims in a case accusing them of overcharging for insulin while paying insurers kickbacks,...

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its...

Sanofi has agreed to produce millions of doses of BioNTech and Pfizer’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts, reported Bloomberg. The...

Sanofi agreed to acquire US biotech company Principia Biopharma for about US$3.4 billion as the French drugmaker pivots toward innovative therapies to spur growth...

Purchasers of a diabetes drug can pursue antitrust claims based on allegations that drugmaker Sanofi-Aventis wrongfully extended its monopoly by improperly listing a patent...

A US appeals court has revived a class action lawsuit alleging Sanofi-Aventis improperly delayed generic versions of its diabetes treatment Lantus from entering the...

Sanofi has agreed to buy cancer biotech company Synthorx for $2.5 billion, the first big move by new Chief Executive Paul Hudson to reinvigorate...